G Brandon Gunn1, Pierre Blanchard2, Adam S Garden1, X Ronald Zhu3, C David Fuller4, Abdallah S Mohamed5, William H Morrison1, Jack Phan1, Beth M Beadle1, Heath D Skinner1, Erich M Sturgis6, Merrill S Kies7, Kate A Hutcheson6, David I Rosenthal1, Radhe Mohan3, Michael T Gillin3, Steven J Frank8. 1. Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. 2. Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Radiation Oncology, Institut Gustave Roussy, Villejuif, France. 3. Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, Texas. 4. Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Medical Physics Program, The University of Texas Graduate School of Biomedical Sciences, Houston, Texas. 5. Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; Department of Clinical Oncology and Nuclear Medicine, University of Alexandria, Egypt. 6. Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas. 7. Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. 8. Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. Electronic address: sjfrank@mdanderson.org.
Abstract
PURPOSE: A single-institution prospective study was conducted to assess disease control and toxicity of proton therapy for patients with head and neck cancer. METHODS AND MATERIALS: Disease control, toxicity, functional outcomes, and patterns of failure for the initial cohort of patients with oropharyngeal squamous carcinoma (OPC) treated with intensity modulated proton therapy (IMPT) were prospectively collected in 2 registry studies at a single institution. Locoregional failures were analyzed by using deformable image registration. RESULTS: Fifty patients with OPC treated from March 3, 2011, to July 2014 formed the cohort. Eighty-four percent were male, 50% had never smoked, 98% had stage III/IV disease, 64% received concurrent therapy, and 35% received induction chemotherapy. Forty-four of 45 tumors (98%) tested for p16 were positive. All patients received IMPT (multifield optimization to n=46; single-field optimization to n=4). No Common Terminology Criteria for Adverse Events grade 4 or 5 toxicities were observed. The most common grade 3 toxicities were acute mucositis in 58% of patients and late dysphagia in 12%. Eleven patients had a gastrostomy (feeding) tube placed during therapy, but none had a feeding tube at last follow-up. At a median follow-up time of 29 months, 5 patients had disease recurrence: local in 1, local and regional in 1, regional in 2, and distant in 1. The 2-year actuarial overall and progression-free survival rates were 94.5% and 88.6%. CONCLUSIONS: The oncologic, toxicity, and functional outcomes after IMPT for OPC are encouraging and provide the basis for ongoing and future clinical studies.
PURPOSE: A single-institution prospective study was conducted to assess disease control and toxicity of proton therapy for patients with head and neck cancer. METHODS AND MATERIALS: Disease control, toxicity, functional outcomes, and patterns of failure for the initial cohort of patients with oropharyngeal squamous carcinoma (OPC) treated with intensity modulated proton therapy (IMPT) were prospectively collected in 2 registry studies at a single institution. Locoregional failures were analyzed by using deformable image registration. RESULTS: Fifty patients with OPC treated from March 3, 2011, to July 2014 formed the cohort. Eighty-four percent were male, 50% had never smoked, 98% had stage III/IV disease, 64% received concurrent therapy, and 35% received induction chemotherapy. Forty-four of 45 tumors (98%) tested for p16 were positive. All patients received IMPT (multifield optimization to n=46; single-field optimization to n=4). No Common Terminology Criteria for Adverse Events grade 4 or 5 toxicities were observed. The most common grade 3 toxicities were acute mucositis in 58% of patients and late dysphagia in 12%. Eleven patients had a gastrostomy (feeding) tube placed during therapy, but none had a feeding tube at last follow-up. At a median follow-up time of 29 months, 5 patients had disease recurrence: local in 1, local and regional in 1, regional in 2, and distant in 1. The 2-year actuarial overall and progression-free survival rates were 94.5% and 88.6%. CONCLUSIONS: The oncologic, toxicity, and functional outcomes after IMPT for OPC are encouraging and provide the basis for ongoing and future clinical studies.
Authors: Jerry D Slater; Les T Yonemoto; David W Mantik; David A Bush; William Preston; Roger I Grove; Daniel W Miller; James M Slater Journal: Int J Radiat Oncol Biol Phys Date: 2005-06-01 Impact factor: 7.038
Authors: Gregory M Chronowski; Adam S Garden; William H Morrison; Steven J Frank; David L Schwartz; Shalin J Shah; Beth M Beadle; G Brandon Gunn; Michael E Kupferman; Kian K Ang; David I Rosenthal Journal: Int J Radiat Oncol Biol Phys Date: 2011-10-20 Impact factor: 7.038
Authors: Adam S Garden; Lei Dong; William H Morrison; Erich M Stugis; Bonnie S Glisson; Steven J Frank; Beth M Beadle; Gary B Gunn; David L Schwartz; Merill S Kies; Randal S Weber; K Kian Ang; David I Rosenthal Journal: Int J Radiat Oncol Biol Phys Date: 2012-09-11 Impact factor: 7.038
Authors: David I Rosenthal; Mark S Chambers; Clifton D Fuller; Neal C S Rebueno; John Garcia; Merrill S Kies; William H Morrison; K Kian Ang; Adam S Garden Journal: Int J Radiat Oncol Biol Phys Date: 2008-05-01 Impact factor: 7.038
Authors: Esengul Kocak-Uzel; G Brandon Gunn; Rivka R Colen; Micheal E Kantor; Abdallah S R Mohamed; Sara Schoultz-Henley; Paniyotis Mavroidis; Steven J Frank; Adam S Garden; Beth M Beadle; William H Morrison; Jack Phan; David I Rosenthal; Clifton D Fuller Journal: Radiother Oncol Date: 2014-04-17 Impact factor: 6.280
Authors: Enzhuo M Quan; Wei Liu; Richard Wu; Yupeng Li; Steven J Frank; Xiaodong Zhang; X Ronald Zhu; Radhe Mohan Journal: Med Phys Date: 2013-08 Impact factor: 4.071
Authors: Xiaorong Ronald Zhu; Falk Poenisch; Heng Li; Xiaodong Zhang; Narayan Sahoo; Richard Y Wu; Xiaoqiang Li; Andrew K Lee; Eric L Chang; Seungtaek Choi; Thomas Pugh; Steven J Frank; Michael T Gillin; Anita Mahajan; David R Grosshans Journal: Radiat Oncol Date: 2014-09-11 Impact factor: 3.481
Authors: Steven J Frank; Pierre Blanchard; J Jack Lee; Erich M Sturgis; Merrill S Kies; Mitchell Machtay; Bhadrasain Vikram; Adam S Garden; David I Rosenthal; G Brandon Gunn; C David Fuller; Katherine Hutcheson; Stephen Lai; Paul M Busse; Nancy Y Lee; Alexander Lin; Robert L Foote Journal: Semin Radiat Oncol Date: 2018-04 Impact factor: 5.934
Authors: N Patrik Brodin; Rafi Kabarriti; Mark Pankuch; Clyde B Schechter; Vinai Gondi; Shalom Kalnicki; Chandan Guha; Madhur K Garg; Wolfgang A Tomé Journal: Int J Radiat Oncol Biol Phys Date: 2018-11-26 Impact factor: 7.038
Authors: Pierre Blanchard; Andrew J Wong; G Brandon Gunn; Adam S Garden; Abdallah S R Mohamed; David I Rosenthal; Joseph Crutison; Richard Wu; Xiaodong Zhang; X Ronald Zhu; Radhe Mohan; Mayankkumar V Amin; C David Fuller; Steven J Frank Journal: Radiother Oncol Date: 2016-09-15 Impact factor: 6.280
Authors: Molly M McCulloch; Brian M Anderson; Guillaume Cazoulat; Christine B Peterson; Abdallah S R Mohamed; Stefania Volpe; Hesham Elhalawani; Houda Bahig; Bastien Rigaud; Jason B King; Alexandra C Ford; Clifton D Fuller; Kristy K Brock Journal: Phys Med Biol Date: 2019-09-05 Impact factor: 3.609
Authors: Pierre Blanchard; Adam S Garden; G Brandon Gunn; David I Rosenthal; William H Morrison; Mike Hernandez; Joseph Crutison; Jack J Lee; Rong Ye; C David Fuller; Abdallah S R Mohamed; Kate A Hutcheson; Emma B Holliday; Nikhil G Thaker; Erich M Sturgis; Merrill S Kies; X Ronald Zhu; Radhe Mohan; Steven J Frank Journal: Radiother Oncol Date: 2016-06-21 Impact factor: 6.280
Authors: Jillian R Gunther; Ahmad R Rahman; Wenli Dong; Zeinab Abou Yehia; Partow Kebriaei; Gabriela Rondon; Chelsea C Pinnix; Sarah A Milgrom; Pamela K Allen; Bouthaina S Dabaja; Grace L Smith Journal: Pract Radiat Oncol Date: 2017-05-10
Authors: Nicolette Taku; Li Wang; Adam S Garden; David I Rosenthal; G Brandon Gunn; William H Morrison; C David Fuller; Jack Phan; Jay P Reddy; Amy C Moreno; Michael T Spiotto; Gregory Chronowski; Shalin J Shah; Lauren L Mayo; Neil D Gross; Renata Ferrarotto; X Ronald Zhu; Xiaodong Zhang; Steven J Frank Journal: Curr Treat Options Oncol Date: 2021-06-04
Authors: Andrew R Barsky; Vishruth K Reddy; John P Plastaras; Edgar Ben-Josef; James M Metz; Andrzej P Wojcieszynski Journal: J Gastrointest Oncol Date: 2020-02